These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3610629)

  • 1. Who should profit from the business of science? The moral limit to private profit in entrepreneurial science.
    Goldworth A
    Hastings Cent Rep; 1987 Jun; 17(3):8-10. PubMed ID: 3610629
    [No Abstract]   [Full Text] [Related]  

  • 2. Who should profit from the business of science? Public money, private gain, profit for all.
    Lomasky LE
    Hastings Cent Rep; 1987 Jun; 17(3):5-7. PubMed ID: 3610628
    [No Abstract]   [Full Text] [Related]  

  • 3. Science innovation. Assessing the impact of science funding.
    Lane J
    Science; 2009 Jun; 324(5932):1273-5. PubMed ID: 19498153
    [No Abstract]   [Full Text] [Related]  

  • 4. Scientific misconduct: individual deviance or system complacency?
    Luft P; Sprague RL
    J Infor Ethics; 1996; 5(1):72-81. PubMed ID: 11653391
    [No Abstract]   [Full Text] [Related]  

  • 5. The business of demographics.
    Russell C
    Popul Bull; 1984 Jun; 39(3):1-40. PubMed ID: 12313263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic science and American business.
    Thomas L
    Bull N Y Acad Med; 1981; 57(6):493-502. PubMed ID: 6941843
    [No Abstract]   [Full Text] [Related]  

  • 7. Bioethics: private choice and common good.
    Callahan D
    Hastings Cent Rep; 1994; 24(3):28-31. PubMed ID: 8089005
    [No Abstract]   [Full Text] [Related]  

  • 8. From spare change to real change. The social sector as beta site for business innovation.
    Kanter RM
    Harv Bus Rev; 1999; 77(3):122-32, 210. PubMed ID: 10387574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. If national health insurance is enacted--who should pay for smokers' medical care?
    Veatch RM; Steinfels P
    Hastings Cent Rep; 1974 Nov; 4(5):8-10. PubMed ID: 4426746
    [No Abstract]   [Full Text] [Related]  

  • 10. Abortion politics, science, and research ethics: take down the wall of separation.
    Fletcher JC
    J Contemp Health Law Policy; 1992; 8():95-121. PubMed ID: 11645741
    [No Abstract]   [Full Text] [Related]  

  • 11. Pushing the borders: the moral dilemma of international Internet pharmacies.
    Cohen JC
    Hastings Cent Rep; 2004; 34(2):15-7. PubMed ID: 15156833
    [No Abstract]   [Full Text] [Related]  

  • 12. The profit motive behind too much medical research.
    Pope John Paul II
    Origins; 2002 Apr; 31(45):754-5. PubMed ID: 12426702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doctoring as business: a study of entrepreneurial medicine in Nigeria.
    Alubo SO
    Med Anthropol; 1990 Aug; 12(3):305-24. PubMed ID: 2233175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoting medical innovation while developing sound social and business policy: a conversation with Thomas G. Roberts. Interview by Barbara J. Culliton.
    Roberts TG
    Health Aff (Millwood); 2008; 27(1):w34-40. PubMed ID: 18042561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fee-for-service research.
    Lind SE
    N Engl J Med; 1986 Jan; 314(5):312-5. PubMed ID: 3941722
    [No Abstract]   [Full Text] [Related]  

  • 16. Some economic aspects of science.
    Johnson HG
    Ciba Found Symp; 1971; 1():161-72. PubMed ID: 5212134
    [No Abstract]   [Full Text] [Related]  

  • 17. Medicine as a business.
    Matthews M
    Mt Sinai J Med; 2004 Sep; 71(4):225-30. PubMed ID: 15365587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essays on science and society. Morals and primordials.
    Guenin LM
    Science; 2001 Jun; 292(5522):1659-60. PubMed ID: 11387460
    [No Abstract]   [Full Text] [Related]  

  • 19. Researchers as professionals, professionals as researchers: a context for laboratory research ethics.
    Elliott D
    Prof Ethics; 1995; 4(3-4):5-16. PubMed ID: 11655041
    [No Abstract]   [Full Text] [Related]  

  • 20. Scientific harassment by pharmaceutical companies: time to stop.
    Hailey D
    CMAJ; 2000 Jan; 162(2):212-3. PubMed ID: 10674057
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.